目的:探讨多元复合声治疗联合口服银杏叶提取物在治疗慢性主观性耳鸣患者中的效果与安全性。方法:选取我院2021年2月至2024年2月收治的60例慢性主观性耳鸣患者作为研究对象,采用随机数字表法分为单一组和联合组,各30例。单一组患者接受...目的:探讨多元复合声治疗联合口服银杏叶提取物在治疗慢性主观性耳鸣患者中的效果与安全性。方法:选取我院2021年2月至2024年2月收治的60例慢性主观性耳鸣患者作为研究对象,采用随机数字表法分为单一组和联合组,各30例。单一组患者接受多元复合声治疗,联合组在单一组的基础上增加口服银杏叶提取物治疗。分别评估两组患者的临床疗效、听力损失程度、耳鸣改善情况[耳鸣严重程度分级量表(Tinnitus Handicap Inventory,THI)]、生活质量[健康状况调查量表(36-Item Short Form Health Survey,SF-36)]、睡眠质量[匹兹堡睡眠质量指数(Pittsburgh Sleep Quality Index,PSQI)]和心理状态[贝克焦虑量表(Beck Anxiety Inventory,BAI)]。结果:联用组的临床总有效率明显高于单一组(P<0.05);治疗后,两组患者的听力损失程度和THI评分、PSQI、BAI评分均明显降低,且联用组明显低于单一组(P<0.05);两组患者的SF-36评分均明显升高,且联用组明显高于单一组(P<0.05)。结论:多元复合声治疗联合口服银杏叶提取物治疗慢性主观性耳鸣患者临床疗效好,可以有效降低听力损伤程度,改善患者的耳鸣症状,提高其生活质量和睡眠质量,促进心理健康。展开更多
目的:采用多元复合声联合经颅直流电刺激(TDCS)治疗慢性主观性耳鸣,观察其疗效。方法:收集160例持续时间 ≥ 6个月的慢性主观性耳鸣患者,实验共分为4组:声治疗组40例(接受多元复合声治疗)、TDCS组40例(接受TDCS治疗)、联合治疗组(接受...目的:采用多元复合声联合经颅直流电刺激(TDCS)治疗慢性主观性耳鸣,观察其疗效。方法:收集160例持续时间 ≥ 6个月的慢性主观性耳鸣患者,实验共分为4组:声治疗组40例(接受多元复合声治疗)、TDCS组40例(接受TDCS治疗)、联合治疗组(接受多元复合声及TDCS治疗)和对照组(不进行任何处理)。所有研究对象填写耳鸣残疾量表,观察治疗后量表评分有无减轻。结果:声治疗组、TDCS组、联合治疗组及对照组的治疗有效率分别为42.50%、37.50%、72.50%、5.00%,对照组与其余三组分别进行对比,差异具有统计学意义。将联合治疗组分别与声治疗组及TDCS组进行对比,差异具有统计学意义。结论:多元复合声治疗及TDCS对慢性耳鸣均有一定的疗效,但二者联合起来的疗效优于单一的治疗方案。Objective: To treat chronic subjective tinnitus with multiple complex sound combined with transcranial direct current stimulation (TDCS) and observe its therapeutic effect. Method: A total of 160 patients with chronic subjective tinnitus with a duration of ≥6 months were collected, and those patients were divided into four groups for the experiment: 40 patients in the sound therapy group (receiving multiple complex sound therapy), 40 patients in the TDCS group (receiving TDCS therapy), 40 patients in the combination therapy group (receiving multiple complex sound and TDCS therapy), and a control group (without any treatment). All research subjects filled out the Tinnitus Disability Scale and observed whether the scale score was reduced after treatment. Result: The effective rates of the sound therapy group, TDCS group, combination therapy group, and control group were 42.50%, 37.50%, 72.50%, and 5.00%, respectively. The control group was compared with the other three groups, and the differences were statistically significant. The combination therapy group was compared with the sound therapy group and TDCS group, and the difference was statistically significant. Conclusion: Both multiple complex sound therapy and TDCS have certain therapeutic effects on chronic tinnitus, but the combined effect of the two is better than a single treatment plan.展开更多
文摘目的:探讨多元复合声治疗联合口服银杏叶提取物在治疗慢性主观性耳鸣患者中的效果与安全性。方法:选取我院2021年2月至2024年2月收治的60例慢性主观性耳鸣患者作为研究对象,采用随机数字表法分为单一组和联合组,各30例。单一组患者接受多元复合声治疗,联合组在单一组的基础上增加口服银杏叶提取物治疗。分别评估两组患者的临床疗效、听力损失程度、耳鸣改善情况[耳鸣严重程度分级量表(Tinnitus Handicap Inventory,THI)]、生活质量[健康状况调查量表(36-Item Short Form Health Survey,SF-36)]、睡眠质量[匹兹堡睡眠质量指数(Pittsburgh Sleep Quality Index,PSQI)]和心理状态[贝克焦虑量表(Beck Anxiety Inventory,BAI)]。结果:联用组的临床总有效率明显高于单一组(P<0.05);治疗后,两组患者的听力损失程度和THI评分、PSQI、BAI评分均明显降低,且联用组明显低于单一组(P<0.05);两组患者的SF-36评分均明显升高,且联用组明显高于单一组(P<0.05)。结论:多元复合声治疗联合口服银杏叶提取物治疗慢性主观性耳鸣患者临床疗效好,可以有效降低听力损伤程度,改善患者的耳鸣症状,提高其生活质量和睡眠质量,促进心理健康。
文摘目的:采用多元复合声联合经颅直流电刺激(TDCS)治疗慢性主观性耳鸣,观察其疗效。方法:收集160例持续时间 ≥ 6个月的慢性主观性耳鸣患者,实验共分为4组:声治疗组40例(接受多元复合声治疗)、TDCS组40例(接受TDCS治疗)、联合治疗组(接受多元复合声及TDCS治疗)和对照组(不进行任何处理)。所有研究对象填写耳鸣残疾量表,观察治疗后量表评分有无减轻。结果:声治疗组、TDCS组、联合治疗组及对照组的治疗有效率分别为42.50%、37.50%、72.50%、5.00%,对照组与其余三组分别进行对比,差异具有统计学意义。将联合治疗组分别与声治疗组及TDCS组进行对比,差异具有统计学意义。结论:多元复合声治疗及TDCS对慢性耳鸣均有一定的疗效,但二者联合起来的疗效优于单一的治疗方案。Objective: To treat chronic subjective tinnitus with multiple complex sound combined with transcranial direct current stimulation (TDCS) and observe its therapeutic effect. Method: A total of 160 patients with chronic subjective tinnitus with a duration of ≥6 months were collected, and those patients were divided into four groups for the experiment: 40 patients in the sound therapy group (receiving multiple complex sound therapy), 40 patients in the TDCS group (receiving TDCS therapy), 40 patients in the combination therapy group (receiving multiple complex sound and TDCS therapy), and a control group (without any treatment). All research subjects filled out the Tinnitus Disability Scale and observed whether the scale score was reduced after treatment. Result: The effective rates of the sound therapy group, TDCS group, combination therapy group, and control group were 42.50%, 37.50%, 72.50%, and 5.00%, respectively. The control group was compared with the other three groups, and the differences were statistically significant. The combination therapy group was compared with the sound therapy group and TDCS group, and the difference was statistically significant. Conclusion: Both multiple complex sound therapy and TDCS have certain therapeutic effects on chronic tinnitus, but the combined effect of the two is better than a single treatment plan.
